Revenue of the vitamins and minerals industry Indonesia 2020-2029

The revenue in the 'Vitamins & Minerals' segment of the otc pharmaceuticals market in Indonesia was forecast to continuously increase between 2024 and 2029 by in total 350.9 million U.S. dollars (+47.18 percent). After the ninth consecutive increasing year, the revenue is estimated to reach 1.1 billion U.S. dollars and therefore a new peak in 2029. Notably, the revenue of the 'Vitamins & Minerals' segment of the otc pharmaceuticals market was continuously increasing over the past years.Find more key insights for the revenue in countries and regions like the revenue change in the otc pharmaceuticals market in Indonesia and the average revenue per capita in the 'Vitamins & Minerals' segment of the otc pharmaceuticals market in Hong Kong. The Statista Market Insights cover a broad range of additional markets.

在印度尼西亚非处方药品市场中的维生素与矿物质细分市场，其收入预计将在2024年至2029年期间持续增长，累计增幅将达到3.509亿美元（增长47.18%）。在连续九年增长之后，预计到2029年，该细分市场的收入将达到11亿美元，从而创下新的历史最高纪录。值得注意的是，过去几年中，印度尼西亚非处方药品市场的维生素与矿物质细分市场的收入一直保持稳定增长态势。欲了解更多关键见解，例如印度尼西亚非处方药品市场的收入变化以及香港非处方药品市场维生素与矿物质细分市场的平均人均收入等，请参阅Statista市场洞察报告。Statista市场洞察涵盖了广泛的附加市场。